Stockstrading
$TLRYTilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.
$GSAT Globalstar’s Band n53 in Qualcomm’s X65 ModemGlobalstar’s Band n53 in Qualcomm’s X65 Modem
Qualcomm to Include Band N53 in New 5G Flagship Modem
The X65 is Qualcomm's flagship 5G modem and adds global 5G band support for n53.
The X65 also offers greater 5G deployment flexibility with increased spectrum aggregation options.
finance.yahoo.com
$AUVI Announces Acquisition of the Airocide Technology PlatformApplied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen Reduction
Developed with NASA as a patented pathogen killing technology
Proprietary photocatalytic oxidation process thoroughly destroys viruses, bacteria, spores, and fungi as well as other carbon-based molecules
Airocide® air disinfection technology compliments and expands the SteriLumen platform, together providing a more comprehensive solution for air and surface
Accelerates the strategy to grow revenues through complimentary acquisitions
Enhances scale in the fast-growing disinfection device market
Akida's revenue for the full calendar year 2020 is estimated to be $4.7 million with EBITDA of approximately $921,000.
Airocide technology is widely accepted and currently used by nationally recognized brands such as Hard Rock Café, the US Army, Stag's Leap vineyards and many more.
finance.yahoo.com
Pricing of $13.6 million Registered Direct Offering Priced ATMSino-Global Shipping America Announces Pricing of Approximately $13.6 million Registered Direct Offering Priced At-The-Market
announced today that it has entered into a securities purchase agreement with certain accredited investors to purchase approximately $13.6 million worth of its common stock in a registered direct offering and warrants to purchase common stock in a concurrent private placement priced at-the-market under Nasdaq rules.
Under the terms of the securities purchase agreement, the Company has agreed to sell approximately 1,998,500 shares of the Company's common stock.
In a concurrent private placement, the Company has agreed to issue unregistered warrants to purchase up to approximately 1,998,500 shares of the Company's common stock. The warrants will be exercisable immediately upon the date of issuance and have an exercise price of $6.805. The warrants will expire 5.5 years from the date of issuance. The purchase price for one share of common stock and a corresponding warrant will be $6.805.
finance.yahoo.com
Closing of an Upsized $20.7 Million Underwritten Public OfferingInspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering
$NSPR today announced the pricing of an upsized underwritten public offering of securities for gross proceeds of $18 million (or $20.7 million if the underwriters exercise their option to purchase additional securities) prior to deducting underwriting discounts and estimated offering expenses payable by InspireMD.
The offering is comprised of 29,032,258 Units, priced at a public offering price of $0.62 per Unit, with each Unit consisting of one share of Common Stock and one Series G Warrant to purchase one-half of one share of Common Stock, at an exercise price of $0.682 per share and expiring on the fifth anniversary of the date of issuance.
finance.yahoo.com
InspireMD Announces Closing of an Upsized $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
$NSPR today announced the closing of an upsized underwritten public offering of units for gross proceeds of approximately $20.7 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares and warrants, prior to deducting underwriting discounts and commissions and offering expenses payable by InspireMD.
finance.yahoo.com
$JG Partners with Kuaishou to Improve Monetization EfficiencyAurora Mobile $JG Partners with Kuaishou to Improve Monetization Efficiency
$JG today announced that it has entered into a partnership agreement with Kuaishou Technology (01024.HK) (“Kuaishou”), China’s leading short video content community and social platform, to improve advertising monetization efficiency.
By leveraging its powerful artificial intelligence (“AI”) and advanced analysis technologies, Aurora Mobile's advertisement SaaS services will enable Kuaishou to help brands and performance-based advertisers to accurately target potential customers, enhance advertising conversion rate, reduce operational costs, and promote a mutually beneficial relationship between Kuaishou and advertisers on its platform.
The short-form video market continues to experience huge growth. Short-form video advertising that features high traffic and conversion rates has become a preferred marketing approach for many brands and performance-based advertisers.
According to the cooperation agreement, Aurora Mobile will benefit from a revenue share agreement based on advertising revenues allocated to Kuaishou if the labels provided by Aurora Mobile are used by advertisers on the platform.
finance.yahoo.com
$MGNI Surges on Its $1.17 Billion Deal for SpotX$MGNI Magnite to Acquire SpotX
Magnite (Nasdaq: MGNI), the largest independent sell-side advertising platform, today announced that it has entered into a definitive agreement to acquire SpotX from RTL Group for $1.17 billion in cash and stock. SpotX is one of the leading platforms shaping CTV and video advertising globally.
Deal Creates Largest Independent CTV & Video Advertising Platform
Full year 2020 combined company estimated non-GAAP net revenue would have been $350 million on a pro forma basis(1)(2)
Combined company Connected TV (CTV) & video net revenue would have represented approximately 67% of total company preliminary non-GAAP pro forma net revenue(1)(2) in Q4 2020
On a combined basis, the CTV business would have nearly tripled to $42 million in Q4 2020 versus Magnite standalone, or approximately 34% of Q4 2020 preliminary non-GAAP pro forma net revenue(1)(2)
The non-CTV video business of the combined company would have represented approximately 33% of Q4 2020 preliminary non-GAAP pro forma net revenue(1)(2)
SpotX total preliminary non-GAAP net revenue(1)(2) for 2020 was $116 million, of which $67 million was CTV
Purchase price consists of $560 million in cash and 14 million shares of Magnite stock, for a total of $1.17 billion based on the closing price of Magnite stock as of February 4, 2021
Magnite’s preliminary results for Q4 2020 include
GAAP Revenue of $82 million, up 69% on an as-reported basis, and up 20% on a pro forma basis from Q4 2019, with CTV revenue of $15.3 million, up 53% on a pro forma basis(1)
Net income of $5.8 million and Adjusted EBITDA(3) of $29.9 million, representing a 36% adjusted EBITDA margin(4)
Together, Magnite and SpotX will serve some of the world’s leading programmers, broadcasters, platforms and device manufacturers, including A+E Networks, Crackle Plus, The CW Network, Discovery, Disney/Hulu, Electronic Arts, Fox Corporation, fuboTV, Microsoft, Newsy, Philo TV, Pluto TV, Roku, Samsung, Sling TV, Tubi, ViacomCBS, Vizio, Vudu, WarnerMedia and Xumo.
finance.yahoo.com
NAKD Brand group LTD stock price to $2.20Hi everyone.
Monitoring the price of the NAKD Brand group.
Opened at my exact entry point, I will not go into too much detail with this stock however, I believe it has the room to rise to $2.20 again.
Take this trade at high caution and trade at your own risk.
My entry: $0.83
This is no way, shape or form is financial advise.
Saif
Why ATA Creativity Skyrocketed 951% yesterdayWhy ATA Creativity Skyrocketed 951% yesterday
There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media.
ATA shares were buoyed — thanks to discussions stock trading groups on Facebook, Discord chat rooms, the r/Daytrading subreddit, Twitter hashtags, and YouTube channels before the market opened.
Many of these posts mentioned the advantages of the high volume and relatively low float (31.74M) of the stock.
ATA Creativity is not on the list of most talked about stocks on r/WallStreetBets, as compiled by Swaggystocks.
PRFX Technical Analysis.If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ALLO Buying from support.If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
BDTX Technical Analysis 🧙Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
$LIZI | Trade Plan Friday 05, 2021$LIZI has been on fire. 3 green days, I was stalking a short entry around 11:00am but did not get it as it showed strength.
For the past 3 days in a row, it's been pushing at market open, I expect same today.
Average time to start fading is around 11:00am - 12:00pm, today I am looking at scalping once it hits the premarket high of 20.09 (very strong resistance). Above 20, it will probably squeeze a little, but I can see today will be first red day.
Short at sight of weakness, breaking uptrend lines, be careful of any share volume above 250K/min. Long at Buy area indicated, confluence of support and trendline (around 13.50 - 13.75 area).
Trade your plan, manage your risk. GL & Happy Friday.
Alziehmer play IdeaAlziehmer play with good vol and Feb 9 Catalyst
milestones for Q1/Q2
1. First Patient In (FPI) for Phase III
(Study 301)
2. Top Line results for completed Phase
I/II (Study 201)
3. Commercial Scale Manufacturing
Batch Pre-IND Meeting Request for AD
Purchase Order for HybridTech Armor© Panels for Aircraft CarrierCPS Technologies Corporation receives Purchase Order for HybridTech Armor© Panels for Aircraft Carrier
CPSH today announced receipt of a purchase order for HybridTech Armor© Panels to be installed as the strike face of advanced ballistic shields to support U.S. Navy CVN class ships.
The purchase order covers panels to equip all crew-served weapons stations on one aircraft carrier.
We have received a $28.7 million IDIQ contract from the Navy to address the aircraft carrier fleet, with an initial delivery order for the first aircraft carrier.”
finance.yahoo.com
Acquires Exclusive Rights to Rare Earth Element InnovationsAmerican Resources Corporation Acquires Exclusive Rights to Purdue University's Rare Earth Element Innovations, Critical for Clean Energy Technologies.
An environmentally safer method of rare earth and other critical material separation and purification using ligand-assisted chromatography for coal, coal byproducts, recycled permanent magnets and Lithium Ion batteries.
Announced that, with the addition of Hasler Ventures LLC, the Company has licensed ligand assisted displacement ("LAD") chromatography patents and knowhow to further expanded its capability in environmentally friendly separation and purification of rare earth elements.
These exclusive patents and technologies, developed at Purdue University, are specific to the processing of separated and pure rare earth metals and critical elements from coal byproducts, recycled permanent magnets and lithium-ion batteries.
Rare earth elements (REEs) include the 15 elements in the lanthanide series plus scandium (Sc) and yttrium (Y). They are essential ingredients for magnets, metal alloys, polishing powders, catalysts, ceramics, and phosphors, which are important for high-technology and clean energy applications. The global REE market is estimated at approximately $4 billion dollars and growing at 8% per year.
finance.yahoo.com
100% Survival Achieved in Osteosarcoma Lung MetastasesMoleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model
a preclinical study in animals demonstrated a potentially significant therapeutic benefit of Annamycin against metastatic osteosarcoma.
Computerized tomography (CT) scans demonstrated that animals treated with Annamycin exhibited significant suppression of tumor growth and not a single death was observed in the treated animals, whereas significant tumor burden contributed to the rapid death of 90% of untreated animals. While the study continues, as of day 130, the survival rate for animals treated with Annamycin was 100%, compared with only 10% for untreated animals.
Annamycin is a "next generation" anthracycline that has recently been shown in animal models to accumulate in the lungs at up to 34 times the level of doxorubicin, which may account for the 100% survival rate attained in this most recent osteosarcoma lung metastases study.
Moleculin recently announced that the FDA has allowed the Company's request for investigational new drug (IND) status in order to study Annamycin for the treatment of soft tissue sarcoma metastasized to the lungs. In addition, the FDA granted Orphan Drug Designation for Annamycin for the treatment of soft tissue sarcomas.
"We expect that one, and potentially two, clinical trials in sarcoma lung metastases should be up and running this year."
finance.yahoo.com
Space launch company Astra to go public via merger with SPAC HOLastra-to-become-the-first-publicly-traded-space-launch-company-on-nasdaq-via-merger-with-holicity
BlackRock-managed funds and accounts lead investment in Astra to launch a new generation of space services to improve life on Earth.
The transaction reflects an implied pro-forma enterprise value for Astra of approximately $2.1 billion. Upon closing, the transaction is expected to provide up to $500 million in cash proceeds, including up to $300 million of cash held in the trust account of Holicity and an upsized $200 million PIPE led by funds and accounts managed by BlackRock.
In December 2020, Astra joined a small, elite group of companies that have made it to space. With over 50 launches in manifest across more than 10 private and public customers, including NASA and DOD, Astra has booked over $150 million of contracted launch revenue. Astra will begin delivering customer payloads this summer and begin monthly launches by the end of this year.
The proposed transaction, which is expected to be completed in the second quarter of 2021.
astra.com
ANVS401 Improves Cognitive and Functional Outcomes in StrokeAnnovis Bio's Lead Candidate ANVS401 Improves Cognitive and Functional Outcomes in Stroke Mice Study
data showing that a combination treatment using the Company's lead candidate ANVS401 and pifithrin after stroke improved mice locomotor activity and cognitive function more so than treatment with just one or the other agent.
While both treatments yielded improvements in locomotor and cognitive function, the combined ANVS401/PFT- treatment proved able to enhance stroke-induced endogenous neurogenesis and improve the functional recovery in stroke animals. The combined treatment also significantly improved cognitive function more than the single treatment with PFT- alone.
finance.yahoo.com
GSM Announces potential financing arrangements being discussedFerroglobe Announces Discussions with Ad Hoc Group of Noteholders and Key Financial Partners
Ferroglobe PLC (the “Company”) entered into confidentiality agreements (the “Confidentiality Agreements”) with certain holders (the “Ad Hoc Group of Noteholders”) of the 9.375% Senior Notes due 2022 (the “Notes”) issued by the Company and Globe Specialty Metals, Inc., to facilitate discussions addressing the maturity of the Notes and the introduction of further capital to the Company.
The key highlights of the potential financing arrangements being discussed between the AHG and the Company are as follows:
A major recapitalization of the business with $100 million of additional liquidity which guarantees sufficient funding to implement the Company’s strategic plan
$60 million of new super senior notes provided by existing Noteholders
$40 million of new equity funding
Significant extension of the Company’s debt maturity profile as a result of a par exchange of the Notes with new senior secured notes with a 5 year tenor
Equity allocation of 3.75% to all supporting holders of the Notes facilitating greater alignment of all stakeholders with management on strategy and long-term value creation
The Company is negotiating with key stakeholders, including its largest shareholder Grupo Villar Mir, S.A.U., the injection of equity that is required to implement the proposed plan and is aiming to enter into a binding agreement with the Ad Hoc Group of Noteholders and equity providers reflecting the outcome of the discussions as soon as possible (although no assurance can be made that the discussions will be successful or that the new funding will be implemented).
The contemplated financings offer Ferroglobe a stronger balance sheet and incremental capital which, in turn, provide a sound foundation for transforming the Company.
the Company has been diligently evaluating various refinancing options to address its senior notes, alongside raising incremental capital.
Collectively we are working towards a comprehensive financing that eliminates near-term refinancing risks, providing greater operational flexibility, and secures cash for the implementation of our plan.
finance.yahoo.com
Post Silver Trade AnalysisDid the initial breakdown for this asset January 6, 2021. Price retraced as fundamentals started to align. When price came back to the same level and showed bullish confirmation on 4hr and Daily, I took the same entry with same Stop Loss and Take Profit. This was supposed to be a position trade but the rallies from the retail investors completed the trade earlier than anticipated.
This Penny Stock NMTR Could soar 462% in 2021The company’s development pipeline features drug candidates under investigation as treatments for short bowel syndrome (SBS) and celiac disease (CeD), two conditions that are both dangerous and difficult to treat.
9 Meters’ flagship product, Larazotide, is in Phase 3 development for the treatment of CeD. CeD affects about 1% of the population, yet there are no approved therapies. Top-line data from the study is expected in the second half of 2021.
Furthermore, this past December, the company announced that it had entered an agreement with EBRIS, the European Biomedical Research Institute of Salerno, to investigate Larazotide as a potential treatment for respiratory complications due to COVID-19.
The other major drug in the company’s pipeline is NM-002, for SBS. The company has recently announced positive Phase 1b/2a results, with a measurable impact on disease symptoms from a compound that was well-tolerated by patients.
ne of these NMTR bulls is Truist’s Srikripa Devarakonda. Citing Larazotide as a key component of his bullish thesis, the analyst noted, “We acknowledge investors are likely to see a pivotal trial in a tough-to-crack Celiac disease program as high risk despite encouraging Ph2b data. We model $705M/$353M in peak unadjusted/adjusted sales and see potential upside of 400% - 1650% from positive Ph3 readout.”
finance.yahoo.com
